Eurofins Scientific SE

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: FR0014000MR3
EUR
62.08
-746.17 (-92.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

414.66 k

Shareholding (Dec 2025)

FII

0.00%

Held by 2 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROCE of 12.82%

  • The company has been able to generate a Return on Capital Employed (avg) of 12.82% signifying low profitability per unit of total capital (equity and debt)
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

With ROE of 1.69%, it has a Very Expensive valuation with a 3.17 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Miscellaneous

stock-summary
Market cap

EUR 11,112 Million ()

stock-summary
P/E

187.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.04%

stock-summary
Debt Equity

1.23

stock-summary
Return on Equity

1.69%

stock-summary
Price to Book

3.14

Revenue and Profits:
Net Sales:
243 Million
(Quarterly Results - Dec 2011)
Net Profit:
23 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-90.85%
0%
-90.85%
6 Months
-87.92%
0%
-87.92%
1 Year
-87.87%
0%
-87.87%
2 Years
-87.78%
0%
-87.78%
3 Years
-90.03%
0%
-90.03%
4 Years
-86.03%
0%
-86.03%
5 Years
-82.82%
0%
-82.82%

Eurofins Scientific SE for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
17.64%
EBIT Growth (5y)
19.39%
EBIT to Interest (avg)
3.53
Debt to EBITDA (avg)
3.15
Net Debt to Equity (avg)
0.82
Sales to Capital Employed (avg)
0.10
Tax Ratio
19.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
12.82%
ROE (avg)
18.36%

Valuation key factors

Factor
Value
P/E Ratio
187
Industry P/E
Price to Book Value
3.17
EV to EBIT
183.62
EV to EBITDA
119.11
EV to Capital Employed
1.98
EV to Sales
18.79
PEG Ratio
1.47
Dividend Yield
1.03%
ROCE (Latest)
1.08%
ROE (Latest)
1.69%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Eurofins Scientific SE"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.96% vs 6.70% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 16.65% vs 31.74% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,296.10",
          "val2": "6,951.00",
          "chgp": "4.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,541.20",
          "val2": "1,417.60",
          "chgp": "8.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "149.30",
          "val2": "141.70",
          "chgp": "5.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-34.20",
          "val2": "-10.90",
          "chgp": "-213.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "473.00",
          "val2": "405.50",
          "chgp": "16.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "112.20%",
          "val2": "104.50%",
          "chgp": "0.77%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
7,296.10
6,951.00
4.96%
Operating Profit (PBDIT) excl Other Income
1,541.20
1,417.60
8.72%
Interest
149.30
141.70
5.36%
Exceptional Items
-34.20
-10.90
-213.76%
Consolidate Net Profit
473.00
405.50
16.65%
Operating Profit Margin (Excl OI)
112.20%
104.50%
0.77%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 4.96% vs 6.70% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 16.65% vs 31.74% in Dec 2024

stock-summaryCompany CV
About Eurofins Scientific SE stock-summary
stock-summary
Eurofins Scientific SE
Miscellaneous
Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain. It is active through Ahma Group, Villapharma, Exova's environment testing laboratories in Eastern Canada, ASL analises ambientais in Brazil, MVZ fur Laboratoriumsmedizin am Hygiene-Institut Gmbh, Alphora Research, Genoma Laboratory Group, Ana Laboratories Inc, Lifecodexx AG, Gatc Biotech AG, Japan Analytical Chemistry Consultants Co. Ltd. (''Jacc''), Tsing Hua and Ecopro Research K.K. (''Ecopro'') and Craft Technologies.
Company Coordinates stock-summary
Company Details
23 val Fleuri , LUXEMBOURG None : 1526
Registrar Details